You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 7, 2025

Drug Price Trends for NDC 46122-0618


✉ Email this page to a colleague

« Back to Dashboard


Average Pharmacy Cost for 46122-0618

Drug Name NDC Price/Unit ($) Unit Date
GNP ALLERGY RELIEF 4 MG TABLET 46122-0618-62 0.01804 EACH 2024-12-18
GNP ALLERGY RELIEF 4 MG TABLET 46122-0618-62 0.01767 EACH 2024-11-20
GNP ALLERGY RELIEF 4 MG TABLET 46122-0618-62 0.02086 EACH 2024-10-23
GNP ALLERGY RELIEF 4 MG TABLET 46122-0618-62 0.01920 EACH 2024-09-18
GNP ALLERGY RELIEF 4 MG TABLET 46122-0618-62 0.02078 EACH 2024-08-21
GNP ALLERGY RELIEF 4 MG TABLET 46122-0618-62 0.02046 EACH 2024-07-17
GNP ALLERGY RELIEF 4 MG TABLET 46122-0618-62 0.01873 EACH 2024-06-19
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Best Wholesale Price for NDC 46122-0618

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Dates Price Type
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

46122-0618 Market Analysis and Financial Projection

Market Analysis and Price Projections for Drug NDC: 46122-0618

Understanding the NDC Directory

To analyze the market and project prices for a specific drug identified by its National Drug Code (NDC), it is crucial to understand the NDC Directory and its components. The FDA's National Drug Code Directory contains detailed information about finished drug products, unfinished drugs, and compounded drug products. Each drug is identified by a unique three-segment NDC number, which serves as the FDA’s identifier for drugs[5].

Identifying the Drug

The NDC 46122-0618 corresponds to a specific drug product. To identify this drug, one would need to search the NDC Directory, which is updated daily and includes information such as the drug name, labeler, pharmacological class, and Drug Enforcement Administration (DEA) schedule[1][5].

Market Dynamics

Drug Pricing Trends

Drug prices in the U.S. have been a subject of significant scrutiny due to their impact on affordability for patients, healthcare payers, and taxpayers. Many prescription drugs have seen substantial price increases over the years. For instance, between 2018 and 2023, nine out of ten drugs selected for Medicare Part D negotiation saw list price increases ranging from 20% to 55%[2].

Regulatory Impact

Regulatory changes and negotiation programs can significantly affect drug prices. The Medicare Drug Price Negotiation Program, for example, is set to implement negotiated prices for certain high-expenditure drugs starting in January 2026. These negotiations have resulted in discounts ranging from 38% to 79% compared to list prices[2].

Market Competition

The presence or absence of generic or biosimilar competition plays a critical role in drug pricing. Drugs selected for negotiation under the Medicare program are typically single-source drugs without generic or biosimilar competition, which can lead to higher prices due to the lack of market competition[2].

Price Projections

Historical Price Analysis

To project future prices, analyzing historical price trends is essential. For the drug with NDC 46122-0618, one would need to review its pricing history, including any changes in the list price, wholesale acquisition cost (WAC), and average transaction prices over the past few years.

Impact of Negotiations and Regulations

If the drug is subject to any negotiation programs or regulatory changes, these factors must be considered in price projections. For example, if the drug is selected for Medicare Part D negotiation, the negotiated price (Maximum Fair Price) will significantly impact its future pricing[2].

Market and Economic Factors

General market and economic factors such as inflation, changes in demand, and advancements in technology can also influence drug prices. For instance, the adoption of artificial intelligence (AI) in pharmaceutical operations could lead to cost savings and potentially affect pricing strategies[3].

Data Sources and Tools

NDC Directory

The FDA's NDC Directory is a primary source for detailed information about the drug, including its pharmacological class, DEA schedule, and marketing status. This directory is updated daily and can be searched online or downloaded as data files[1][5].

Medicare Data

For drugs covered under Medicare, analyzing data from the Centers for Medicare & Medicaid Services (CMS) can provide insights into pricing trends and negotiated prices. This includes comparing list prices, WAC, and average transaction prices over time[2].

Industry Reports and Predictions

Industry reports and predictions from experts can offer valuable insights into future trends. For example, predictions about the increased use of AI and external data in pharmaceutical operations could indicate potential changes in drug development and pricing strategies[3].

Case Study: Medicare Part D Negotiations

The Medicare Drug Price Negotiation Program provides a clear example of how regulatory actions can impact drug prices. For the first cycle of negotiation, ten drugs were selected, and the negotiated prices resulted in significant discounts. This model can be used to understand how similar negotiations might affect the price of the drug with NDC 46122-0618 if it were to be selected for such a program[2].

Key Takeaways

  • NDC Directory: A crucial resource for identifying and gathering detailed information about drug products.
  • Historical Price Analysis: Essential for understanding past trends and projecting future prices.
  • Regulatory Impact: Negotiation programs and regulatory changes can significantly affect drug prices.
  • Market Competition: The presence or absence of generic or biosimilar competition is a key factor in pricing.
  • Economic and Market Factors: General economic conditions and technological advancements can influence pricing strategies.

FAQs

What is the NDC Directory and how is it used?

The NDC Directory is a database maintained by the FDA that contains information about finished drug products, unfinished drugs, and compounded drug products. It is used to identify drugs using their unique NDC numbers and provides details such as pharmacological class and DEA schedule[1][5].

How do regulatory changes affect drug prices?

Regulatory changes, such as negotiation programs under Medicare Part D, can significantly reduce drug prices by introducing negotiated prices that are often lower than list prices. These changes aim to make prescription drugs more affordable for patients and taxpayers[2].

What role does AI play in pharmaceutical pricing?

AI is increasingly being adopted in pharmaceutical operations, including clinical development and data analysis. This can lead to cost savings and more efficient drug development processes, potentially influencing pricing strategies in the future[3].

How often is the NDC Directory updated?

The NDC Directory is updated daily to ensure it includes the most current information on listed drugs in their final marketed form[1][5].

What are the key factors in projecting drug prices?

Key factors include historical price trends, regulatory changes, market competition, and general economic and technological advancements. Analyzing these factors helps in making accurate price projections[2][3][5].

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.